OPPM
Opus Point Partners Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $677K | Buy |
2,439
+218
| +10% | +$60.5K | 1.22% | 17 |
|
|
2019
Q2 | $695K | Buy |
2,221
+20
| +0.9% | +$6.26K | 1.03% | 22 |
|
|
2019
Q1 | $904K | Sell |
2,201
-315
| -13% | -$129K | 1.23% | 17 |
|
|
2018
Q4 | $940K | Sell |
2,516
-15
| -0.6% | -$5.6K | 2.07% | 12 |
|
|
2018
Q3 | $1.02M | Sell |
2,531
-167
| -6% | -$67.5K | 2.44% | 18 |
|
|
2018
Q2 | $931K | Buy |
2,698
+76
| +3% | +$26.2K | 2.02% | 21 |
|
|
2018
Q1 | $903K | Sell |
2,622
-1,454
| -36% | -$501K | 1.77% | 18 |
|
|
2017
Q4 | $1.53M | Sell |
4,076
-485
| -11% | -$182K | 1.33% | 23 |
|
|
2017
Q3 | $2.04M | Buy |
4,561
+29
| +0.6% | +$13K | 1.83% | 23 |
|
|
2017
Q2 | $2.23M | Sell |
4,532
-3,503
| -44% | -$1.72M | 2.04% | 14 |
|
|
2017
Q1 | $3.11M | Buy |
8,035
+351
| +5% | +$136K | 2.31% | 22 |
|
|
2016
Q4 | $2.82M | Buy |
7,684
+172
| +2% | +$63.1K | 2.25% | 18 |
|
|
2016
Q3 | $3.02M | Buy |
7,512
+279
| +4% | +$112K | 1.69% | 17 |
|
|
2016
Q2 | $2.53M | Sell |
7,233
-1,696
| -19% | -$592K | 2.44% | 17 |
|
|
2016
Q1 | $3.22M | Sell |
8,929
-1,785
| -17% | -$643K | 2.49% | 18 |
|
|
2015
Q4 | $5.82M | Buy |
10,714
+87
| +0.8% | +$47.2K | 3.84% | 6 |
|
|
2015
Q3 | $4.94M | Buy |
10,627
+1,868
| +21% | +$869K | 2.73% | 10 |
|
|
2015
Q2 | $4.47M | Buy |
8,759
+9
| +0.1% | +$4.59K | 3.54% | 10 |
|
|
2015
Q1 | $3.95M | Buy |
8,750
+100
| +1% | +$45.1K | 3.31% | 7 |
|
|
2014
Q4 | $3.55M | Buy |
+8,650
| New | +$3.55M | 3.51% | 7 |
|